Ana Lukić

PET Imaging of Tau Pathology and Relationship to Amyloid, Longitudinal MRI, and Cognitive Change in Down Syndrome: Results from the Down Syndrome Biomarker Initiative (DSBI)

Michael S. Rafii, Ana Lukić, Randolph D. Andrews et al. · Journal of Alzheimer s Disease · 2017 · 99 citations

Riluzole, a glutamate modulator, slows cerebral glucose metabolism decline in patients with Alzheimer’s disease

Dawn Matthews, Xiangling Mao, Kathleen Dowd et al. · Brain · 2021 · 92 citations · Full text

Neurochemical Biomarkers, Alzheimer ’, Glutamatergic Neural Circuits +22

FDG PET Parkinson’s disease-related pattern as a biomarker for clinical trials in early stage disease

Dawn C. Matthews, Hedva Lerman, Ana Lukić et al. · NeuroImage Clinical · 2018 · 89 citations · Full text

Physical Activity, Mediterranean Diet and Biomarkers-Assessed Risk of Alzheimer’s: A Multi-Modality Brain Imaging Study

Dawn C. Matthews, Michelle Davies, John Murray et al. · Advances in Molecular Imaging · 2014 · 70 citations · Full text

GM‐CSF– and M‐CSF–primed macrophages present similar resolving but distinct inflammatory lipid mediator signatures

Ana Lukić, Pia Larssen, Alexander Fauland et al. · The FASEB Journal · 2017 · 68 citations